Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease

Keyphrases

• Genetic Modification 100%
• Fibroblasts 100%
• L-DOPA 100%
• Rat Model of Parkinson's Disease 100%
• Caudate 33%
• Tyrosine 33%
• Gene Therapy 33%
• Parkinson's Disease 33%
• Retroviral Vector 33%
• Nigrostriatal Pathway 33%
• Complementary DNA (cDNA) 33%
• Neurological Diseases 33%
• Control Cell 33%
• Immunohistochemical Staining 33%
• Oxidoreductase 33%
• Tyrosine Hydroxylase 33%
• Pterin 33%
• Cell Culture Media 33%
• 6-hydroxydopamine Lesion 33%
• Rat Fibroblasts 33%
• Tetrahydropteridines 33%
• Tyrosine 3-monooxygenase 33%
• Rotational Asymmetry 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Parkinson's Disease 100%
• Rat Model 100%
• Tyrosine 3 Monooxygenase 100%
• Cell Culture 50%
• Complementary DNA 50%
• Neurologic Disease 50%
• Retrovirus Vector 50%
• Oxidoreductase 50%
• Pterin 50%
• Oxidopamine 50%

Biochemistry, Genetics and Molecular Biology

• Rat Model 100%
• Fibroblast 100%
• Tyrosine Hydroxylase 75%
• Tyrosine 25%
• Oxidoreductase 25%
• Gene Therapy 25%
• Retrovirus Vector 25%
• Cell Culture 25%